BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 36615496)

  • 1. Chemistry and Biological Activities of Naturally Occurring and Structurally Modified Podophyllotoxins.
    Jin L; Song Z; Cai F; Ruan L; Jiang R
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in semisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: an update (2008-2010).
    Lv M; Xu H
    Mini Rev Med Chem; 2011 Sep; 11(10):901-9. PubMed ID: 21781026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007.
    Xu H; Lv M; Tian X
    Curr Med Chem; 2009; 16(3):327-49. PubMed ID: 19149581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in the Chemistry and Biology of Podophyllotoxins.
    Yu X; Che Z; Xu H
    Chemistry; 2017 Apr; 23(19):4467-4526. PubMed ID: 27726183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic and application perspectives of azapodophyllotoxins: alternative scaffolds of podophyllotoxin.
    Kumar A; Kumar V; Alegria AE; Malhotra SV
    Curr Med Chem; 2011; 18(25):3853-70. PubMed ID: 21824101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments towards podophyllotoxin congeners as potential apoptosis inducers.
    Kamal A; Hussaini SM; Malik MS
    Anticancer Agents Med Chem; 2015; 15(5):565-74. PubMed ID: 25469512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podophyllotoxin: History, Recent Advances and Future Prospects.
    Shah Z; Gohar UF; Jamshed I; Mushtaq A; Mukhtar H; Zia-Ui-Haq M; Toma SI; Manea R; Moga M; Popovici B
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic Agents. 585. Isolation of Bridelia ferruginea Anticancer Podophyllotoxins and Synthesis of 4-Aza-podophyllotoxin Structural Modifications.
    Pettit GR; Searcy JD; Tan R; Cragg GM; Melody N; Knight JC; Chapuis JC
    J Nat Prod; 2016 Mar; 79(3):507-18. PubMed ID: 26938998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A multivariate analysis approach to antineoplastic and antiviral structure-activity relationships to a series of podophyllotoxins].
    Doré JC; Viel C; Pageot N; Gordaliza M; Castro A; del Corral JM; Feliciano AS
    J Pharm Belg; 1996; 51(1):9-18. PubMed ID: 8882445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podophyllotoxins: current status and recent developments.
    Damayanthi Y; Lown JW
    Curr Med Chem; 1998 Jun; 5(3):205-52. PubMed ID: 9562603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of podophyllotoxins.
    Imbert TF
    Biochimie; 1998 Mar; 80(3):207-22. PubMed ID: 9615861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic cyclolignans related to podophyllotoxin.
    Gordaliza M; Miguel del Corral JM; Angeles Castro M; García-García PA; San Feliciano A
    Farmaco; 2001 Apr; 56(4):297-304. PubMed ID: 11421258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-based anticancer molecules: a chemical and biological profile of some important leads.
    Srivastava V; Negi AS; Kumar JK; Gupta MM; Khanuja SP
    Bioorg Med Chem; 2005 Nov; 13(21):5892-908. PubMed ID: 16129603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor.
    Hernández ÁP; Díez P; García PA; Pérez-Andrés M; Ortega P; Jambrina PG; Díez D; Castro MÁ; Fuentes M
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32957517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemistry and Biology of Podophyllotoxins: An Update.
    Hao M; Xu H
    Chemistry; 2024 Jan; 30(4):e202302595. PubMed ID: 37814110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 4α/4β-imidazolyl podophyllotoxin analogues as antitumor agents.
    Shang H; Chen H; Zhao D; Tang X; Liu Y; Pan L; Cheng M
    Arch Pharm (Weinheim); 2012 Jan; 345(1):43-8. PubMed ID: 21956645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor properties of podophyllotoxin and related compounds.
    Gordaliza M; Castro MA; del Corral JM; Feliciano AS
    Curr Pharm Des; 2000 Dec; 6(18):1811-39. PubMed ID: 11102564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of novel spin-labeled derivatives of podophyllotoxin as potential antineoplastic agents. Part XII.
    Yang L; Liu YQ; Tan H; Li WG; Tian X
    Nat Prod Res; 2007 Sep; 21(11):998-1008. PubMed ID: 17691049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity, Post-Treatment Recovery, and Selectivity Analysis of Naturally Occurring Podophyllotoxins from Bursera fagaroides var. fagaroides on Breast Cancer Cell Lines.
    Peña-Morán OA; Villarreal ML; Álvarez-Berber L; Meneses-Acosta A; Rodríguez-López V
    Molecules; 2016 Aug; 21(8):. PubMed ID: 27527135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs that inhibit tubulin polymerization: the particular case of podophyllotoxin and analogues.
    Desbène S; Giorgi-Renault S
    Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):71-90. PubMed ID: 12678752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.